The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis

Background: Persistence and adherence to disease-modifying therapies (DMTs) affects treatment efficacy and economic outcomes, both of which contribute to overall patient disease burden. Current literature suggests that patients with multiple sclerosis (MS) who adhere to DMT for 12 months have fewer...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardo, Gabriel, Pineda, Elmor D., Ng, Carmen D., Sheinson, Daniel, Bonine, Nicole G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2022
Materias:
Neurological Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043544/
https://www.ncbi.nlm.nih.gov/pubmed/35586512
http://dx.doi.org/10.36469/jheor.2022.33288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043544/
https://www.ncbi.nlm.nih.gov/pubmed/35586512
http://dx.doi.org/10.36469/jheor.2022.33288

Ejemplares similares